On the contrary, other studies have indicated beneficial outcomes in cancer patients treated with GLP-1 RA, with anti-obesity effects and direct anti-cancer effects on cancer cells [114]. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.